Feasibility and Usability of a Chest-Strap Ambulatory ECG Monitor in Active Individuals in Comparison With a Traditional Ambulatory ECG Patch Monitor (MoMe ARC)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorMayo Clinic

About this trial

The purpose of this research is to compare the standard ambulatory ECG monitor, the MoMe ARC, against Fourth Frontier's "Frontier X Plus". This device is an FDA-Cleared chest-strap-based ECG wearable that provides an alternative modality to capture ambulatory ECG rhythm changes.

Eligibility criteria

Qualifiers

Adult participants (>22 years; Frontier X is approved for use in this age group) who participate in >4 days a week of >150 minutes total per week of moderate to high intensity exercise who were prescribed a ambulatory ECG monitor for clinical purposes for 24 hours or more.

Patients must agree to wear the Frontier X monitor for the prescribed duration and use the Frontier X Plus application

Disqualifiers

Current use of Implanted Cardiac Devices

Pregnancy

Known allergies to any of the materials listed in the "List of Patient-Contacting Materials"

Presence of skin injuries or broken skin in the area where the chest strap is worn

Trial design

Treatments tested in this trial

  • Frontier X Plus chest-strap ECG device
  • MoMe ARC ambulatory ECG monitor

Treatment groups

15 Participants
are divided into 1 treatment group

Sponsors and collaborators